Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $15.83 in the last session, up 2.19% from day before closing price of $15.49. In other words, the price has increased by $2.19 from its previous closing price. On the day, 0.55 million shares were traded. VRDN stock price reached its highest trading level at $15.845 during the session, while it also had its lowest trading level at $15.2403.
Ratios:
We take a closer look at VRDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 23.99 and its Current Ratio is at 23.99. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on June 11, 2024, initiated with a Outperform rating and assigned the stock a target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 22 ’24 when Fairmount Funds Management LLC bought 476,190 shares for $21.00 per share. The transaction valued at 9,999,990 led to the insider holds 1,839,954 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1011377088 and an Enterprise Value of 662327424. For the stock, the TTM Price-to-Sale (P/S) ratio is 3487.51 while its Price-to-Book (P/B) ratio in mrq is 2.64. Its current Enterprise Value per Revenue stands at 2299.748 whereas that against EBITDA is -2.647.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $24.18, while it has fallen to a 52-week low of $10.93. The 50-Day Moving Average of the stock is 12.74%, while the 200-Day Moving Average is calculated to be -3.51%.
Shares Statistics:
According to the various share statistics, VRDN traded on average about 1.05M shares per day over the past 3-months and 704780 shares per day over the past 10 days. A total of 63.89M shares are outstanding, with a floating share count of 55.51M. Insiders hold about 13.11% of the company’s shares, while institutions hold 96.06% stake in the company. Shares short for VRDN as of 1722384000 were 8488252 with a Short Ratio of 8.07, compared to 1719532800 on 7915953. Therefore, it implies a Short% of Shares Outstanding of 8488252 and a Short% of Float of 15.6.
